Crossmark

Response to letter to editor for risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1007/s12072-024-10664-8

Published Online: 2024-02-29

Published Print: 2024-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Park, Jin Wook

Yoo, Jeong-Ju https://orcid.org/0000-0002-7802-0381
Kim, Sang Gyune

Kim, Young Seok
License Information

Text and Data Mining valid from 2024-02-29

Version of Record valid from 2024-02-29
More Information

Article History

Received: 4 January 2024

Accepted: 13 February 2024

First Online: 29 February 2024

Declarations

:

: The authors declare that there is no conflict of interest relevant to this study.

Document is current

Any future updates will be listed below